IVTY SEC फाइलिंग - Invuity, Inc.- वार्षिक रिपोर्ट, प्रॉक्सी स्टेटमेंट, प्रॉस्पेक्टस

मूलभूत आँकड़े

CIK

1393020

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Invuity, Inc.

SEC Filings (Chronological Order)

यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।

February 14, 2019	SC 13G/A	IVTY / Invuity, Inc. / Partner Fund Management, L.P. - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Invuity, Inc. (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 46187J205 (CUSIP Number) December 31, 2018 Date of Event Which Requires Filing
February 12, 2019	SC 13G/A	IVTY / Invuity, Inc. / Flynn James E Passive Investment SC 13G/A 1 e618216sc13ga-invuity.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 6) * Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) December 31, 2018
November 2, 2018	15-12B	IVTY / Invuity, Inc. 15-12B 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-37417 Invuity, Inc. (Exact name of registrant as specified in its
October 29, 2018	SC 13G/A	IVTY / Invuity, Inc. / Novo A/S - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Invuity, Inc. (Name of Issuer) Common Stock (Title of class of securities) 46187J106 (CUSIP number) October 23, 2018 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this S
October 29, 2018	SC 13D/A	IVTY / Invuity, Inc. / GARDNER LEWIS ASSET MANAGEMENT L P Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Invuity, Inc. (Name of Issuer) Common Stock, $ 0.001 par value (Title of Class of Securities) 46187J205 (CUSIP Number) Gardner Lewis Asset Management, L.P. Attn: Len Sorgini, Chief Compliance Officer 285 Wilmington West Chester Pike, Chadds Ford, PA 1931
October 23, 2018	S-8 POS	IVTY / Invuity, Inc. S-8 POS S-8 POS As filed with the Securities and Exchange Commission on October 23, 2018 Registration Nos.
October 23, 2018	S-8 POS	IVTY / Invuity, Inc. S-8 POS S-8 POS As filed with the Securities and Exchange Commission on October 23, 2018 Registration Nos.
October 23, 2018	S-8 POS	IVTY / Invuity, Inc. S-8 POS S-8 POS As filed with the Securities and Exchange Commission on October 23, 2018 Registration Nos.
October 23, 2018	POS AM	IVTY / Invuity, Inc. POS AM POS AM 1 d640141dposam.htm POS AM As filed with the Securities and Exchange Commission on October 23, 2018 Registration No. 333-212395 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT NO. 333-212395 UNDER THE SECURITIES ACT OF 1933 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 0
October 23, 2018	EX-3.2	Amended and Restated Bylaws of Invuity, Inc. EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF INVUITY, INC. Section 1. LAW, CERTIFICATE OF INCORPORATION AND BYLAWS 1.1. These bylaws are subject to the certificate of incorporation of the corporation (the “Certificate of Incorporation”). In these bylaws, references to law, the Certificate of Incorporation and bylaws mean the law, the provisions of the Certificate of Incorporation and these by
October 23, 2018	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2018 Invuity, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File
October 23, 2018	EX-3.1	Amended and Restated Certificate of Incorporation of Invuity, Inc. EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INVUITY, INC. 1. The name of the corporation is: Invuity, Inc. 2. The address of its registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, in the City of Wilmington, County of New Castle, 19801. The name of its registered agent at such address is The Corporation Trust Company. 3. The purpo
October 23, 2018	SC 14D9/A	IVTY / Invuity, Inc. SC 14D9/A SC 14D9/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4) INVUITY, INC. (Name of Subject Company) INVUITY, INC. (Name of Person Filing Statement) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J205 (CUSIP Number of Class of Sec
October 23, 2018	EX-99.(A)(5)(A)	2825 Airview Boulevard EX-99.(a)(5)(A) Exhibit (a)(5)(A) 2825 Airview Boulevard Kalamazoo, MI 49002 Press release Stryker completes acquisition of Invuity, Inc. Kalamazoo, Michigan – October 23, 2018 – Stryker (NYSE:SYK) announced today the completion of its previously announced acquisition of Invuity, Inc. Invuity is the leader in advanced photonics and single-use, lighted instruments that deliver enhanced visualizatio
October 23, 2018	SC TO-T/A	SYK / Stryker Corp. SC TO-T/A SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR SECTION 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3) INVUITY, INC. (Name of Subject Company (Issuer)) ACCIPITER CORP. a wholly-owned subsidiary of STRYKER CORPORATION (Name of Filing Persons (Offerors)) Common Stock, $0.001 Par Value Pe
October 16, 2018	SC 14D9/A	IVTY / Invuity, Inc. SC 14D9/A SC 14D9/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3) INVUITY, INC. (Name of Subject Company) INVUITY, INC. (Name of Person Filing Statement) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J205 (CUSIP Number of Class of Sec
October 11, 2018	SC TO-T/A	SYK / Stryker Corp. SC TO-T/A SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR SECTION 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2) INVUITY, INC. (Name of Subject Company (Issuer)) ACCIPITER CORP. a wholly-owned subsidiary of STRYKER CORPORATION (Name of Filing Persons (Offerors)) Common Stock, $0.001 Par Value Pe
October 10, 2018	SC 14D9/A	IVTY / Invuity, Inc. SC 14D9/A SC 14D9/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2) INVUITY, INC. (Name of Subject Company) INVUITY, INC. (Name of Person Filing Statement) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J205 (CUSIP Number of Class of Sec
October 4, 2018	SC 13D	IVTY / Invuity, Inc. / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communicat
October 1, 2018	SC 14D9/A	IVTY / Invuity, Inc. SC 14D9/A SC 14D9/A 1 d632134dsc14d9a.htm SC 14D9/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) INVUITY, INC. (Name of Subject Company) INVUITY, INC. (Name of Person Filing Statement) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J2
October 1, 2018	SC TO-T/A	SYK / Stryker Corp. SC TO-T/A SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR SECTION 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) INVUITY, INC. (Name of Subject Company (Issuer)) ACCIPITER CORP. a wholly-owned subsidiary of STRYKER CORPORATION (Name of Filing Persons (Offerors)) Common Stock, $0.001 Par Value Pe
September 24, 2018	EX-99.(E)(11)	INVUITY, INC. EXECUTIVE CHANGE OF CONTROL AGREEMENT EX-99.(e)(11) Exhibit (e)(11) INVUITY, INC. EXECUTIVE CHANGE OF CONTROL AGREEMENT This Executive Change of Control Agreement (the “Agreement”) is entered into by and between Invuity, Inc. (the “Company”), and Steve Annen (“Executive”) as of the date set forth on the signature page below (the “Effective Date”). 1. Background. (a) Executive is employed by the Company as the Company’s Vice President
September 24, 2018	EX-99.(E)(9)	INVUITY, INC. EXECUTIVE CHANGE OF CONTROL AGREEMENT EX-99.(e)(9) Exhibit (e)(9) INVUITY, INC. EXECUTIVE CHANGE OF CONTROL AGREEMENT This Executive Change of Control Agreement (the “Agreement”) is entered into by and between Invuity, Inc. (the “Company”), and Douglas Heigel (“Executive”) as of the date set forth on the signature page below (the “Effective Date”). This Agreement, together with the Executive Change of Control Agreement dated as of eve
September 24, 2018	EX-99.(E)(10)	INVUITY, INC. EXECUTIVE SEVERANCE AGREEMENT EX-99.(e)(10) Exhibit (e)(10) INVUITY, INC. EXECUTIVE SEVERANCE AGREEMENT This Executive Severance Agreement (the “Agreement”) is entered into by and between Invuity, Inc. (the “Company”), and Douglas Heigel (“Executive”) as of the date set forth on the signature page below (the “Effective Date”). This Agreement, together with the Executive Change of Control Agreement dated as of even date herewit
September 24, 2018	EX-99.(E)(3)	August 8, 2018 EX-99.(e)(3) Exhibit (e)(3) August 8, 2018 PRIVATE AND CONFIDENTIAL Invuity, Inc. 444 De Haro Street San Francisco, CA 94107 Attention: Scott Flora, Interim President and Chief Executive Officer Dear Scott: This letter agreement (the “Letter Agreement”) sets forth certain understandings between Stryker Corporation (“Stryker”) and Invuity, Inc. (the “Company” and, together with Stryker, the “partie
September 24, 2018	EX-99.(E)(4)	September 7, 2018 EX-99.(e)(4) Exhibit (e)(4) September 7, 2018 PRIVATE AND CONFIDENTIAL Invuity, Inc. 444 De Haro Street San Francisco, CA 94107 Re: Exclusivity Period Dear Scott: Reference is hereby made to the letter agreement, dated August 8, 2018 (the “Letter Agreement”), by and between Stryker Corporation (“Stryker”), and Invuity, Inc. (the “Company”) which contemplates a possible strategic business combinati
September 24, 2018	SC 14D9	IVTY / Invuity, Inc. SC 14D9 SC 14D9 Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 INVUITY, INC. (Name of Subject Company) INVUITY, INC. (Name of Person Filing Statement) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J205 (CUSIP Number of Class of Secur
September 24, 2018	EX-99.(E)(13)	INVUITY, INC. EXECUTIVE CHANGE OF CONTROL AGREEMENT EX-99.(e)(13) Exhibit (e)(13) INVUITY, INC. EXECUTIVE CHANGE OF CONTROL AGREEMENT This Executive Change of Control Agreement (the “Agreement”) is entered into by and between Invuity, Inc. (the “Company”), and Hisham Shiblaq (“Executive”) as of May 1, 2018 (the “Effective Date”). 1. Background. (a) Executive is employed by the Company as the Company’s Vice President, Commercial Operations. (b) The
September 24, 2018	EX-99.(A)(2)	September 24, 2018 EX-99.(a)(2) Exhibit (a)(2) September 24, 2018 Dear Stockholder: On behalf of the board of directors of Invuity, Inc., I am pleased to inform you that on September 10, 2018, Invuity agreed to be acquired by Stryker Corporation (“Stryker”), pursuant to the terms of an Agreement and Plan of Merger (the “Merger Agreement”) by and among Invuity, Stryker and Accipiter Corp., a wholly owned subsidiary o
September 24, 2018	EX-99.(E)(15)	INVUITY, INC. EXECUTIVE SEVERANCE AGREEMENT EX-99.(e)(15) Exhibit (e)(15) INVUITY, INC. EXECUTIVE SEVERANCE AGREEMENT This Executive Severance Agreement (the “Agreement”) is entered into by and between Invuity, Inc. (the “Company”), and Hisham Shiblaq (“Executive”) as of May 1, 2018 (the “Effective Date”). 1. Background. (a) Executive is employed by the Company as the Company’s Vice President, Commercial Operations. (b) The purpose of this
September 24, 2018	EX-99.(E)(12)	INVUITY, INC. EXECUTIVE SEVERANCE AGREEMENT EX-99.(e)(12) Exhibit (e)(12) INVUITY, INC. EXECUTIVE SEVERANCE AGREEMENT This Executive Severance Agreement (the “Agreement”) is entered into by and between Invuity, Inc. (the “Company”), and Steve Annen (“Executive”) as of the date set forth on the signature page below (the “Effective Date”). This Agreement, together with the Executive Change of Control Agreement dated as of even date herewith,
September 24, 2018	EX-99.(E)(14)	AMENDMENT TO EXECUTIVE CHANGE OF CONTROL AGREEMENT EX-99.(e)(14) Exhibit (e)(14) AMENDMENT TO EXECUTIVE CHANGE OF CONTROL AGREEMENT THIS AMENDMENT TO EXECUTIVE CHANGE OF CONTROL AGREEMENT (this “Amendment”), is made and entered into this 8th day of August, 2018, by and between Hisham Shiblaq (hereafter “Executive”) and Invuity, Inc., having a place of business at 444 De Haro Street, San Francisco, CA 94107 (hereafter “Company”). This agreement ame
September 24, 2018	EX-99.(A)(1)(A)	OFFER TO PURCHASE FOR CASH All Outstanding Shares of Common Stock INVUITY, INC. $7.40 Per Share ACCIPITER CORP. a wholly-owned subsidiary of STRYKER CORPORATION EX-99.(a)(1)(A) Table of Contents Exhibit (a)(1)(A) OFFER TO PURCHASE FOR CASH All Outstanding Shares of Common Stock of INVUITY, INC. at $7.40 Per Share by ACCIPITER CORP. a wholly-owned subsidiary of STRYKER CORPORATION THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT EASTERN TIME AT THE END OF THE DAY ON OCTOBER 22, 2018 UNLESS THE OFFER IS EXTENDED OR EARLIER TERMINATED. Accipiter
September 24, 2018	EX-99.(A)(1)(C)	Offer to Purchase for Cash All Outstanding Shares of Common Stock INVUITY, INC. $7.40 Per Share Pursuant to the Offer to Purchase Dated September 24, 2018 ACCIPITER CORP. a wholly-owned subsidiary of STRYKER CORPORATION EX-99.(a)(1)(C) Exhibit (a)(1)(C) Offer to Purchase for Cash All Outstanding Shares of Common Stock of INVUITY, INC. at $7.40 Per Share Pursuant to the Offer to Purchase Dated September 24, 2018 by ACCIPITER CORP. a wholly-owned subsidiary of STRYKER CORPORATION THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT EASTERN TIME AT THE END OF THE DAY ON OCTOBER 22, 2018, UNLESS THE OFFER IS
September 24, 2018	EX-99.(A)(1)(E)	Notice of Offer to Purchase for Cash All Outstanding Shares of Common Stock INVUITY, INC. at $7.40 Per Share Pursuant to the Offer to Purchase dated September 24, 2018 ACCIPITER CORP. a wholly-owned subsidiary of STRYKER CORPORATION EX-99.(a)(1)(E) Exhibit (a)(1)(E) This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below), and the provisions herein are subject in their entirety to the provisions of the Offer (as defined below). The Offer is made solely pursuant to the Offer to Purchase, dated September 24, 2018, and the related Letter of Transmittal and any amendments
September 24, 2018	EX-99.(A)(1)(B)	Letter of Transmittal To Tender Shares of Common Stock INVUITY, INC. $7.40 Per Share Pursuant to the Offer to Purchase Dated September 24, 2018 ACCIPITER CORP. a wholly-owned subsidiary of STRYKER CORPORATION EX-99.(a)(1)(B) Exhibit (a)(1)(B) Letter of Transmittal To Tender Shares of Common Stock of INVUITY, INC. at $7.40 Per Share Pursuant to the Offer to Purchase Dated September 24, 2018 by ACCIPITER CORP. a wholly-owned subsidiary of STRYKER CORPORATION THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT EASTERN TIME AT THE END OF THE DAY ON OCTOBER 22, 2018 UNLESS THE OFFER IS EXTENDED OR
September 24, 2018	EX-99.(D)(2)	Invuity, Inc. 444 De Haro Street San Francisco, CA 94107 July 31, 2018 EX-99.(d)(2) Exhibit (d)(2) Invuity, Inc. 444 De Haro Street San Francisco, CA 94107 July 31, 2018 CONFIDENTIAL Stryker Instruments 4100 E. Milham Avenue Kalamazoo, MI 49001 Confidentiality Agreement Ladies and Gentlemen: In connection with your consideration of a potential acquisition or negotiated business combination transaction involving Invuity, Inc., a Delaware corporation (together with its
September 24, 2018	EX-99.(A)(1)(D)	Offer to Purchase for Cash All Outstanding Shares of Common Stock INVUITY, INC. $7.40 Per Share Pursuant to the Offer to Purchase Dated September 24, 2018 ACCIPITER CORP. a wholly-owned subsidiary of STRYKER CORPORATION EX-99.(a)(1)(D) Exhibit (a)(1)(D) Offer to Purchase for Cash All Outstanding Shares of Common Stock of INVUITY, INC. at $7.40 Per Share Pursuant to the Offer to Purchase Dated September 24, 2018 by ACCIPITER CORP. a wholly-owned subsidiary of STRYKER CORPORATION THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 12:00 MIDNIGHT EASTERN TIME AT THE END OF THE DAY ON OCTOBER 22, 2018, UNLESS THE OFFER IS
September 24, 2018	SC TO-T	SYK / Stryker Corp. SC TO-T SC TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR SECTION 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 INVUITY, INC. (Name of Subject Company (Issuer)) ACCIPITER CORP. a wholly-owned subsidiary of STRYKER CORPORATION (Name of Filing Persons (Offerors)) Common Stock, $0.001 Par Value Per Share (Title of Cl
September 24, 2018	SC 13D	IVTY / Invuity, Inc. / GARDNER LEWIS ASSET MANAGEMENT L P Activist Investment SC 13D 1 ivty091218.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Invuity, Inc. (Name of Issuer) Common Stock, $ 0.01 par value (Title of Class of Securities) 46187J205 (CUSIP Number) Gardner Lewis Asset Management, L.P. Attn: Len Sorgini, Chief Compliance Officer 285 Wilmington West Chester Pike
September 13, 2018	SC 13G/A	IVTY / Invuity, Inc. / Arkin Moshe - SC 13G/A Passive Investment SC 13G/A 1 zk1822090.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Invuity, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J205 (CUSIP Number) September 12, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched
September 11, 2018	EX-99.1	Form of letter sent to Invuity customers, first used on September 11, 2018 Exhibit 99.1 Dear Valued Customer:
September 11, 2018	SC14D9C	IVTY / Invuity, Inc. SC14D9C SC14D9C 1 a18-280671sc14d9c.htm SC14D9C SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 INVUITY, INC. (Name of Subject Company) INVUITY, INC. (Name of Person Filing Statement) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J205 (CUSIP Number of
September 11, 2018	EX-99.2	Form of letter sent to Invuity employees, first used on September 11, 2018 Exhibit 99.2 Hello Team Invuity, This morning, we announced that Invuity has entered into a definitive agreement to be acquired by Stryker with an expected close in the fourth quarter of 2018 pending certain corporate procedures and customary regulatory approvals. Our suite of products enabling better visualization in surgery, in combination with Stryker’s well-established leadership in minimal ac
September 11, 2018	EX-99.1	2825 Airview Boulevard EX-99.1 2 d621850dex991.htm EX-99.1 Exhibit 99.1 2825 Airview Boulevard Kalamazoo, MI 49002 Number: 2018-25 Date: September 11, 2018 Stryker announces definitive agreement to acquire Invuity, Inc. Kalamazoo, Michigan – September 11, 2018 – Stryker (NYSE: SYK) announced today a definitive agreement to acquire all the issued and outstanding shares of common stock of Invuity, Inc. (NASDAQ: IVTY) for
September 11, 2018	SC TO-C	SYK / Stryker Corp. SC TO-C SC TO-C 1 d621850dsctoc.htm SC TO-C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR SECTION 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 INVUITY, INC. ACCIPITER CORP. a wholly owned subsidiary of STRYKER CORPORATION (Name of Filing Persons (Offerors)) Common Stock, $0.001 Par Value Per Share (Title of Class of
September 11, 2018	EX-99.2	Invuity Announces Definitive Agreement to Be Acquired by Stryker Corporation for $7.40 per Share in Cash EX-99.2 5 a18-271801ex99d2.htm EX-99.2 Exhibit 99.2 Invuity Announces Definitive Agreement to Be Acquired by Stryker Corporation for $7.40 per Share in Cash San Francisco, CA, September 11, 2018 — Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on advanced surgical devices to enable better visualization, today announced it has entered into a definitive agreement with Str
September 11, 2018	EX-2.1	Agreement and Plan of Merger, dated September 10, 2018, by and among Stryker Corporation, Accipiter Corp. and Invuity, Inc. * Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among STRYKER CORPORATION, ACCIPITER CORP. and INVUITY, INC., Dated as of September 10, 2018 Table of Contents Page Number Section 1 - THE OFFER AND THE MERGER 2 1.1. The Offer 2 1.2. Company Actions 4 1.3. The Merger 5 1.4. Effective Time 6 1.5. The Closing 6 1.6. Directors and Officers of the Surviving Corporation 6 1.7. Subsequen
September 11, 2018	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2018 Invuity, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File N
September 11, 2018	EX-99.1	TENDER AGREEMENT Exhibit 99.1 TENDER AGREEMENT PREAMBLE THIS Tender Agreement (this “Agreement”), dated September 10, 2018, is by and between Stryker Corporation, a Delaware corporation (“Parent”), Accipiter Corp., a Delaware corporation and direct or indirect wholly owned Subsidiary of Parent (“Sub”), and (“Stockholder”), with respect to (a) the shares of common stock, par value $0.001 per share (the “Shares”), o
September 11, 2018	EX-3.1	Amendment to Amended and Restated Bylaws of Invuity, Inc., dated September 10, 2018 EX-3.1 3 a18-271801ex3d1.htm EX-3.1 Exhibit 3.1 AMENDMENT TO AMENDED AND RESTATED BYLAWS OF INVUITY, INC. a Delaware corporation Pursuant to a resolution duly adopted by the Board of Directors of Invuity, Inc., a Delaware corporation, effective September 10, 2018, the Amended and Restated Bylaws are amended as follows: “Section 9.5 FORUM FOR ADJUDICATION OF DISPUTES Unless the corporation consents
August 3, 2018	EX-10.2	Amendment No. 3 to Credit and Security Agreement (Revolving Loan), dated as of July 31, 2018, by and among the Company, MidCap Financial Trust, as Agent, and the lenders party thereto. Exhibit 10.2 Execution Version amendment No. 3 to CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) This AMENDMENT NO. 3 TO CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) (this “Agreement”) is made as of this 31st day of July, 2018, by and among INVUITY, INC., a Delaware corporation (“Invuity”), MidCap Funding IV Trust, as successor Agent to MidCap Financial Trust (in such capacity, together with its
August 3, 2018	10-Q	IVTY / Invuity, Inc. 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10‑Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37417
August 3, 2018	EX-10.1	Amendment No. 3 to Credit and Security Agreement (Term Loan), dated as of July 31, 2018, by and among the Company, MidCap Financial Trust, as Agent, and the lenders party thereto. Exhibit 10.1 Execution Version AMENDMENT NO. 3 TO CREDIT AND SECURITY AGREEMENT (TERM LOAN) This AMENDMENT NO. 3 TO CREDIT AND SECURITY AGREEMENT (TERM LOAN) (this “Agreement”) is made as of this 31st day of July, 2018, by and among INVUITY, INC., a Delaware corporation (“Invuity”), MIDCAP FINANCIAL TRUST, as Agent (in such capacity, together with its successors and assigns, “Agent”), and the othe
August 2, 2018	EX-99.1	INVUITY ANNOUNCES 2018 SECOND QUARTER, SIX-MONTH FINANCIAL RESULTS EX-99.1 2 ex-99d1.htm EX-99.1 Exhibit 99.1 NEWS RELEASE INVUITY ANNOUNCES 2018 SECOND QUARTER, SIX-MONTH FINANCIAL RESULTS SAN FRANCISCO, August 2, 2018 - Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced financial results for the second quarter and six months ended June 30, 2018. Q2 2018 Highlights · Second quarter 2018 revenue gr
August 2, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 2, 2018 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employ
June 12, 2018	8-K	Submission of Matters to a Vote of Security Holders SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 11, 2018 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File No.) (IRS Employer I
May 25, 2018	SD	IVTY / Invuity, Inc. SD SD 1 a18-142981sd.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Commission File Number: 001-37417 INVUITY, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3803169 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 444 De Haro Street, San Francisco, Califor
May 24, 2018	EX-99	Joint Filing Agreement Exhibit 1 Joint Filing Agreement Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Invuity, Inc.
May 24, 2018	EX-99	Board Resolution Arkin Communications Ltd. ("The Company") Exhibit 2 Board Resolution Arkin Communications Ltd. ("The Company") RESOLVED THAT: The signatory rights in the name of the Company, starting from 15/04/2015 Will be as follows: The signature of the Following person: Moshe Arkin holder of Identity Card No: Together with the Company's stamp, or The Company's printed name shall bind the Company for all intents and purposes. Moshe Arkin, Sole Directo
May 24, 2018	SC 13G	IVTY / Invuity, Inc. / Arkin Moshe - SC 13G Passive Investment SC 13G 1 zk1821730.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Invuity, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J205 (CUSIP Number) May 14, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed
May 4, 2018	EX-10.6	Executive Change in Control Agreement, dated December 2, 2016, by and between the Company and Andrew Sale. Exhibit 10.6 INVUITY, INC. EXECUTIVE CHANGE OF CONTROL AGREEMENT This Executive Change of Control Agreement (the “Agreement”) is entered into by and between Invuity, Inc. (the “Company”), and Andy Sale (“Executive”) as of the date set forth on the signature page below (the “Effective Date”). 1. Background. (a) Executive is employed by the Company as the Company’s Senior Vice President, Global Sale
May 4, 2018	EX-10.4	Amendment No. 2 to Credit and Security Agreement (Revolving Loan), dated as of April 30, 2018, by and among the Company, MidCap Financial Trust, as Agent, and the lenders party thereto. Exhibit 10.4 Execution Version AMENDMENT NO. 2 TO CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) This AMENDMENT NO. 2 TO CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) (this “Agreement”) is made as of this 30th day of April, 2018, by and among INVUITY, INC., a Delaware corporation (“Invuity”), MidCap Funding IV Trust, as successor Agent to MidCap Financial Trust (in such capacity, together with it
May 4, 2018	EX-10.3	Amendment No. 2 to Credit and Security Agreement (Term Loan), dated as of April 30, 2018, by and among the Company, MidCap Financial Trust, as Agent, and the lenders party thereto. Exhibit 10.3 Execution Version AMENDMENT NO. 2 TO CREDIT AND SECURITY AGREEMENT (TERM LOAN) This AMENDMENT NO. 2 TO CREDIT AND SECURITY AGREEMENT (TERM LOAN) (this “Agreement”) is made as of this 30th day of April, 2018, by and among INVUITY, INC., a Delaware corporation (“Invuity”), MIDCAP FINANCIAL TRUST, as Agent (in such capacity, together with its successors and assigns, “Agent”), and the oth
May 4, 2018	10-Q	IVTY / Invuity, Inc. 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10‑Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-3741
May 4, 2018	EX-10.5	Executive Severance Agreement, dated December 2, 2016, by and between the Company and Andrew Sale. Exhibit 10.5 INVUITY, INC. EXECUTIVE SEVERANCE AGREEMENT This Executive Severance Agreement (the “Agreement”) is entered into by and between Invuity, Inc. (the “Company”), and Andy Sale (“Executive”) as of the date set forth on the signature page below (the “Effective Date”). 1. Background. (a) Executive is employed by the Company as the Company’s Senior Vice President, Global Sales. (b) The purpo
May 4, 2018	EX-10.7	Offer Letter dated November 16, 2016, by and between the Company and Andrew Sale. Exhibit 10.7 November 16, 2016 Andy Sale 1500 Fleetwood Drive Franklin, TN 37064 Re: Your Employment With Invuity, Inc. Dear Andy: Invuity, Inc. (the “Company”) is pleased to offer you employment with the Company on the terms described below. 1. Position. You will serve in a full-time position as the Senior Vice President, Global Sales starting November 21, 2016 (your “Hire Date”) and you will rep
May 3, 2018	EX-99.1	INVUITY ANNOUNCES FIRST QUARTER FINANCIAL RESULTS EX-99.1 2 ex-99d1.htm EX-99.1 Exhibit 99.1 NEWS RELEASE INVUITY ANNOUNCES FIRST QUARTER FINANCIAL RESULTS SAN FRANCISCO, May 3, 2018 - Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announces financial results for the three months ended March 31, 2018. Q1 2018 Highlights · First quarter 2018 revenue grew 5.3% to $9.5 million compared to r
May 3, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 f8-k.htm 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 3, 2018 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File Num
April 26, 2018	DEFA14A	IVTY / Invuity, Inc. DEFA14A DEFA14A 1 a18-30373defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as
April 26, 2018	DEF 14A	IVTY / Invuity, Inc. DEF 14A Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 16, 2018	EX-99.1	INVUITY ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK Exhibit 99.1 NEWS RELEASE INVUITY ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK SAN FRANCISCO, March 15, 2018 — Invuity, Inc. (NASDAQ:IVTY) (“Invuity” or the “Company”), a leading medical technology company focused on minimal access surgery, today announced the pricing of its public offering of 6,200,000 shares of its common stock at a price to the public of $3.50 per share. In addition, th
March 16, 2018	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 a18-847918k.htm 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 15, 2018 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commissio
March 16, 2018	EX-1.1	Underwriting Agreement, dated March 15, 2018, by and between Invuity, Inc., and William Blair & Company, L.L.C., as representative of the several underwriters named therein. Exhibit 1.1 Execution Version 6,200,000 Shares Invuity, Inc. Common Stock UNDERWRITING AGREEMENT March 15, 2018 WILLIAM BLAIR & COMPANY, L.L.C., As Representative of the several Underwriters named in Schedule I hereto c/o William Blair & Company, L.L.C. 150 North Riverside Plaza Chicago, Illinois 60606 Ladies and Gentlemen: Invuity, Inc., a Delaware corporation (the “Company”) proposes to sell to
March 15, 2018	424B5	6,200,000 Shares INVUITY, INC. Common Stock $3.50 per share Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No.
March 14, 2018	424B5	Subject to completion, dated March 14, 2018 Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No.
March 6, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 5, 2018 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employe
March 6, 2018	EX-10.2	Employment Agreement, dated March 6, 2018, by and between the Company and Scott Flora. Exhibit 10.2 INVUITY, INC. EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is entered into by and between Invuity, Inc. (the “Company”), and Scott Flora (“Executive”) as of the date the Company and Executive have each executed this Agreement, as set forth below. The terms of this Agreement will become effective on March 1, 2018 (the “Effective Date”). 1. Duties and Scope
March 6, 2018	EX-10.1	Separation Agreement and Release, dated March 5, 2018, by and between the Company and Philip Sawyer. Exhibit 10.1 SEPARATION AGREEMENT AND RELEASE This Separation Agreement and Release (“Agreement”) is made by and between Philip Sawyer (“Employee”) and Invuity, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”). RECITALS WHEREAS, Employee was employed by the Company and served as a member of its Board of Directors (the “Board”); WHEREAS, Empl
March 5, 2018	S-8	IVTY / Invuity, Inc. S-8 As filed with the Securities and Exchange Commission on March 5, 2018 Registration No.
March 5, 2018	10-K	IVTY / Invuity, Inc. 10-K (Annual Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-374
February 14, 2018	SC 13G/A	IVTY / Invuity, Inc. / Partner Fund Management, L.P. - SC 13G/A Passive Investment SC 13G/A 1 tv484526sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Invuity, Inc. (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 46187J205 (CUSIP Number) December 31, 20
February 14, 2018	SC 13G/A	IVTY / Invuity, Inc. / INTERWEST PARTNERS X LP - SC 13G/A Passive Investment SC 13G/A OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2010 Estimated average burden hours per response .
February 14, 2018	EX-99.A	Joint Filing Statement EX-99.A EXHIBIT A Joint Filing Statement We, the undersigned, hereby express our agreement that the attached Schedule 13G is filed on behalf of each of us. Date: February 14, 2018 INTERWEST PARTNERS X, LP By: InterWest Management Partners X, LLC, its General Partner By: /s/ Gilbert H. Kliman Managing Director INTERWEST MANAGEMENT PARTNERS X, LLC By: /s/ Gilbert H. Kliman Managing Director By: /s/
February 14, 2018	SC 13G/A	IVTY / Invuity, Inc. / Flynn James E Passive Investment SC 13G/A 1 e617651sc13ga-invuity.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 5) * Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) December 31, 2017
February 14, 2018	EX-99.A	JOINT FILING AGREEMENT EX-A CUSIP No. 46187J205 EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other reporting persons on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, par value $0.001 per share of Invuity,
February 14, 2018	SC 13G/A	IVTY / Invuity, Inc. / HealthCare Royalty Partners II, L.P. - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 2)* Under the Securities Exchange Act of 1934 INVUITY, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J205 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the
February 13, 2018	EX-99.1	INVUITY ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS Exhibit99.1 Exhibit 99.1 NEWS RELEASE INVUITY ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS SAN FRANCISCO, February 13th, 2018 - Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announces financial results for the three months and year ended December 31, 2017. Q4 and full year 2017 Highlights ? Fourth quarter 2017 revenue gr
February 13, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition ivtyCurrentFolio8K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 13, 2018 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission Fi
February 2, 2018	SC 13G/A	IVTY / Invuity, Inc. / Novo A/S - SCHEDULE 13G/A (AMENDMENT NO. 3) Passive Investment SC 13G/A 1 d531462dsc13ga.htm SCHEDULE 13G/A (AMENDMENT NO. 3) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Invuity, Inc. (Name of Issuer) Common Stock (Title of class of securities) 46187J106 (CUSIP number) December 31, 2017 (Date of event which requires filing of this statement) Check the appropr
February 2, 2018	SC 13G	IVTY / Invuity, Inc. / HARTFORD MUTUAL FUNDS INC/CT - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) 12/31/2017 (Date of Event Which Requires
January 8, 2018	SC 13D/A	IVTY / Invuity, Inc. / Discovery Group I, LLC - SCHEDULE 13D (AMENDMENT NO. 3) Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* Invuity, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J
January 8, 2018	EX-3	POWER OF ATTORNEY EXHIBIT 3 POWER OF ATTORNEY The undersigned, Michael R. Murphy, hereby appoints Mark Buckley his true and lawful attorney-in-fact and agent, with full power to execute and file with the United States Securities and Exchange Commission and any stock exchange or similar authority, for and on his behalf in any and all capacities, any and all reports required to be filed pursuant to Section 13 of the
January 8, 2018	EX-1	TRANSACTIONS SINCE THOSE REPORTED IN THE SCHEDULE 13D FILED ON DECEMBER 15, 2017 EXHIBIT 1 TRANSACTIONS SINCE THOSE REPORTED IN THE SCHEDULE 13D FILED ON DECEMBER 15, 2017 The Reporting Persons engaged in the following transactions in shares of Common Stock of the Company since those reported in the Schedule 13D filed by the Reporting Persons on December 15, 2017.
January 8, 2018	EX-2	JOINT FILING AGREEMENT EXHIBIT 2 JOINT FILING AGREEMENT The undersigned hereby agree to the joint filing of the Amendment No.
December 15, 2017	EX-3	POWER OF ATTORNEY EXHIBIT 3 POWER OF ATTORNEY The undersigned, Michael R. Murphy, hereby appoints Mark Buckley his true and lawful attorney-in-fact and agent, with full power to execute and file with the United States Securities and Exchange Commission and any stock exchange or similar authority, for and on his behalf in any and all capacities, any and all reports required to be filed pursuant to Section 13 of the
December 15, 2017	SC 13D/A	IVTY / Invuity, Inc. / Discovery Group I, LLC - SCHEDULE 13D (AMENDMENT NO. 2) Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* Invuity, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J
December 15, 2017	EX-1	TRANSACTIONS DURING THE PAST 60 DAYS EXHIBIT 1 TRANSACTIONS DURING THE PAST 60 DAYS The Reporting Persons engaged in the following transactions in shares of Common Stock of the Company during the 60-day period preceding this filing.
December 15, 2017	EX-2	JOINT FILING AGREEMENT EXHIBIT 2 JOINT FILING AGREEMENT The undersigned hereby agree to the joint filing of the Amendment No.
November 22, 2017	EX-24	LIMITED POWER OF ATTORNEY — SECURITIES LAW COMPLIANCE Exhibit 24 LIMITED POWER OF ATTORNEY ? SECURITIES LAW COMPLIANCE The undersigned, as a Section 16 reporting person of Invuity, Inc.
November 21, 2017	EX-99.1	INVUITY APPOINTS SCOTT FLORA TO BOARD OF DIRECTORS Exhibit 99.1 NEWS RELEASE INVUITY APPOINTS SCOTT FLORA TO BOARD OF DIRECTORS SAN FRANCISCO, November 21, 2017 (GLOBE NEWSWIRE) ? Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that Scott D. Flora has been appointed to its Board of Directors, effective November 21, 2017. Mr. Flora, who brings more than 30 years of medical device
November 21, 2017	8-K	IVTY / Invuity, Inc. 8-K (Current Report) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 20, 2017 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Emp
November 7, 2017	EX-99.1	INVUITY REPORTS 2017 THIRD QUARTER FINANCIAL RESULTS Full Launch of PhotonBlade® Completed Exhibit99.1 Exhibit 99.1 NEWS RELEASE INVUITY REPORTS 2017 THIRD QUARTER FINANCIAL RESULTS Full Launch of PhotonBlade? Completed SAN FRANCISCO, November 7, 2017 - Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today reported financial results for the quarter ended September 30, 2017. Q3 2017 Highlights ? Revenue grew 13% to $9.6 million compare
November 7, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition ivtyCurrentFolio8K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 7, 2017 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission Fil
November 7, 2017	10-Q	IVTY / Invuity, Inc. 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10‑Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-
September 27, 2017	8-K	Invuity 8-K (Current Report/Significant Event) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 26, 2017 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Em
September 27, 2017	EX-10.3	Warrant to Purchase Stock, dated as of September 26, 2017, by Invuity, Inc. in favor of MidCap Funding XXVIII Trust. Exhibit 10.3 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ACT), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF SECTION 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW, OR
September 27, 2017	EX-10.1	Amendment No. 1 to Credit and Security Agreement (Term Loan), dated as of September 26, 2017, by and among Invuity, Inc., MidCap Financial Trust, as Agent, and the lenders party thereto. Exhibit 10.1 Execution Version AMENDMENT NO. 1 TO CREDIT AND SECURITY AGREEMENT (TERM LOAN) This AMENDMENT NO. 1 TO CREDIT AND SECURITY AGREEMENT (TERM LOAN) (this Agreement) is made as of this 26th day of September, 2017, by and among INVUITY, INC., a Delaware corporation (Invuity), MidCap Financial Trust, as Agent (in such capacity, together with its successors and assigns, Agent), and the
September 27, 2017	EX-10.2	Amendment No. 1 to Credit and Security Agreement (Revolving Loan), dated as of September 26, 2017, by and among Invuity, Inc., MidCap Financial Trust, as Agent, and the lenders party thereto. Exhibit 10.2 Execution Version AMENDMENT NO. 1 TO CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) This AMENDMENT NO. 1 TO CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) (this ?Agreement?) is made as of this 26th day of September, 2017, by and among INVUITY, INC., a Delaware corporation (?Invuity?), MidCap Funding IV Trust, as successor Agent to MidCap Financial Trust (in such capacity, together wit
September 27, 2017	EX-10.4	Warrant to Purchase Stock, dated as of September 26, 2017, by Invuity, Inc. in favor of Apollo Investment Corporation. Exhibit 10.4 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF SECTION 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW, OR
September 27, 2017	EX-99.1	INVUITY DRAWS $10 MILLION SECOND TRANCHE OF TERM LOAN Exhibit 99.1 NEWS RELEASE INVUITY DRAWS $10 MILLION SECOND TRANCHE OF TERM LOAN SAN FRANCISCO, September 27, 2017 - Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it has drawn $10 million in additional borrowings under an amended debt agreement with MidCap Financial (MidCap). The MidCap facility consists of a $30 million
September 27, 2017	EX-10.5	Warrant to Purchase Stock, dated as of September 26, 2017, by Invuity, Inc. in favor of Flexpoint MCLS Holdings LLC. Exhibit 10.5 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ACT), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF SECTION 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW, OR
September 20, 2017	SC 13D/A	IVTY / Invuity, Inc. / Discovery Group I, LLC - SCHEDULE 13D (AMENDMENT NO. 1) Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Invuity, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J
September 20, 2017	EX-1	TRANSACTIONS SINCE THOSE REPORTED IN THE SCHEDULE 13D FILED BY THE REPORTING PERSONS ON AUGUST 31, 2017 EXHIBIT 1 TRANSACTIONS SINCE THOSE REPORTED IN THE SCHEDULE 13D FILED BY THE REPORTING PERSONS ON AUGUST 31, 2017 The Reporting Persons engaged in the following transactions in shares of Common Stock of the Company since those reported in the Schedule 13D filed by the Reporting Persons on August 31, 2017.
September 20, 2017	EX-3	POWER OF ATTORNEY EXHIBIT 3 POWER OF ATTORNEY The undersigned, Michael R. Murphy, hereby appoints Mark Buckley his true and lawful attorney-in-fact and agent, with full power to execute and file with the United States Securities and Exchange Commission and any stock exchange or similar authority, for and on his behalf in any and all capacities, any and all reports required to be filed pursuant to Section 13 of the
September 20, 2017	EX-2	JOINT FILING AGREEMENT EXHIBIT 2 JOINT FILING AGREEMENT The undersigned hereby agree to the joint filing of the Amendment No.
September 18, 2017	EX-99.1	JOINT FILING AGREEMENT EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the common stock of Invuity, Inc., a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on behalf of each of the undersigned
September 18, 2017	SC 13G	IVTY / Invuity, Inc. / Partner Fund Management, L.P. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. )* Invuity, Inc. (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 46187J205 (CUSIP Number) September 7, 2017 Date of Event Which Requires Filing of
September 7, 2017	EX-24	LIMITED POWER OF ATTORNEY ? SECURITIES LAW COMPLIANCE Exhibit 24 LIMITED POWER OF ATTORNEY ? SECURITIES LAW COMPLIANCE The undersigned, as a Section 16 reporting person of Invuity, Inc.
August 31, 2017	EX-2	JOINT FILING AGREEMENT EXHIBIT 2 JOINT FILING AGREEMENT The undersigned hereby agree to the joint filing of the Schedule 13D to which this Agreement is attached. Dated: August 31, 2017 DISCOVERY EQUITY PARTNERS, L.P. By Michael R. Murphy* Michael R. Murphy Manager DISCOVERY GROUP I, LLC By Michael R. Murphy * Michael R. Murphy Manager *By: /s/ Mark Buckley Mark Buckley Attorney-in-Fact for Michael R. Murphy
August 31, 2017	EX-3	POWER OF ATTORNEY EX-3 4 v474459ex3.htm EXHIBIT 3 EXHIBIT 3 POWER OF ATTORNEY The undersigned, Michael R. Murphy, hereby appoints Mark Buckley his true and lawful attorney-in-fact and agent, with full power to execute and file with the United States Securities and Exchange Commission and any stock exchange or similar authority, for and on his behalf in any and all capacities, any and all reports required to be file
August 31, 2017	EX-1	TRANSACTIONS DURING PAST 60 DAYS EX-1 2 v474459ex1.htm EXHIBIT 1 EXHIBIT 1 TRANSACTIONS DURING PAST 60 DAYS The Reporting Persons engaged in the following transactions in shares of Common Stock of the Company during the past 60 days. Such transactions involved the purchase of shares on the NASDAQ Global Market. Certain of the prices reported below reflect the weighted average purchase price of the shares of Common Stock purchased
August 31, 2017	SC 13D	IVTY / Invuity, Inc. / Discovery Group I, LLC - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Invuity, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J2
August 30, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits 8-K 1 a17-2109618k.htm 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 29, 2017 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commiss
August 30, 2017	EX-99.1	DANIEL WOLTERMAN JOINS INVUITY’S BOARD OF DIRECTORS Exhibit 99.1 NEWS RELEASE DANIEL WOLTERMAN JOINS INVUITYS BOARD OF DIRECTORS SAN FRANCISCO, August 30, 2017 - Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, announced today that healthcare industry leader Daniel Wolterman has been appointed to its Board of Directors, effective September 5, 2017. Wolterman was most recently President & Chief Ex
July 26, 2017	EX-10.1	Invuity, Inc. Restricted Stock Unit Deferral Program for Outside Directors. Exhibit 10.1 Invuity, Inc. Restricted Stock unit Deferral Program for Outside Directors The Invuity, Inc. Restricted Stock Unit Deferral Program for Outside Directors (the “Program”) has been adopted by the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of Invuity, Inc. (the “Company”) in accordance with the provisions of the Invuity, Inc. 2015 Equity Incentive Pl
July 26, 2017	EX-10.2	Invuity, Inc. Restricted Stock Unit Deferral Program for Outside Directors Award Notice. Exhibit 10.2 INVUITY, INC. RESTRICTED STOCK UNIT DEFERRAL PROGRAM FOR OUTSIDE DIRECTORS TERMS AND CONDITIONS OF DEFERRED RESTRICTED STOCK UNIT GRANT Deferred RSU Award Notice (this “Award Notice”) for: This Award Notice evidences the award of deferred Restricted Stock Units (each, a “Deferred RSU” or collectively, the “Deferred RSUs”) that have been granted to, [NAME], by Invuity, Inc. (the “Compa
July 26, 2017	10-Q	IVTY / Invuity, Inc. 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10‑Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37417
July 25, 2017	EX-99.1	INVUITY REPORTS 2017 SECOND QUARTER, SIX-MONTH FINANCIAL RESULTS Achieves revenue growth of 19% over prior year quarter Updates 2017 revenue guidance Exhibit99.1 Exhibit 99.1 NEWS RELEASE INVUITY REPORTS 2017 SECOND QUARTER, SIX-MONTH FINANCIAL RESULTS Achieves revenue growth of 19% over prior year quarter Updates 2017 revenue guidance SAN FRANCISCO, July 25, 2017 - Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today reported financial results for the three months and six months ended June
July 25, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition ivtyCurrentFolio8K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 25, 2017 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File N
June 13, 2017	8-K	Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders CurrentFolio8Knon-Fin SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 12, 2017 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission Fil
June 13, 2017	EX-99.1	Invuity Provides Update on PhotonBlade Commercialization Exhibit99.1 Exhibit 99.1 NEWS RELEASE Invuity Provides Update on PhotonBlade Commercialization SAN FRANCISCO, June 13, 2017 - Invuity, Inc. (NASDAQ:IVTY), a medical technology company focused on minimal access surgery, today provided an update on plans for PhotonBlade commercialization. As previously announced, the Company began a limited market release of PhotonBlade in March, 2017. During this p
May 9, 2017	POS EX	Invuity POS EX As filed with the Securities and Exchange Commission on May 9, 2017. Registration No. 333- 212395 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Invuity, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3803169 (State or other jurisdiction of incorporation or organiz
April 28, 2017	DEFA14A	Invuity DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State
April 28, 2017	DEF 14A	Invuity DEF 14A Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
April 27, 2017	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10‑Q 10-Q 1 ivty-20170331x10q.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10‑Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fr
April 26, 2017	EX-99.1	INVUITY REPORTS 2017 FIRST QUARTER RESULTS Achieves revenue growth of 41% and gross margin expansion over prior year quarter Exhibit99.1 Exhibit 99.1 NEWS RELEASE INVUITY REPORTS 2017 FIRST QUARTER RESULTS Achieves revenue growth of 41% and gross margin expansion over prior year quarter SAN FRANCISCO, April 26, 2017 - Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today reported financial results for the three months ended March 31, 2017. Q1 2017 Highlights ? Revenue
April 26, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 f8-k.htm 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 26, 2017 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File
March 20, 2017	10-K/A	Invuity 10-K/A (Annual Report) ivtyCurrentFolio10KA UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 16, 2017	EX-4.9	Warrant to Purchase Stock, dated as of March 10, 2017, by Invuity, Inc. in favor of Flexpoint MCLS Holdings LLC. Exhibit 4.9 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF SECTION 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW, OR S
March 16, 2017	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-374
March 16, 2017	EX-10.6	Credit and Security Agreement (Term Loan), dated as of March 10, 2017, by and among Invuity, Inc., MidCap Financial Trust, as Agent, and the lenders party thereto. Exhibit 10.6 Execution Version CREDIT AND SECURITY AGREEMENT (TERM LOAN) dated as of March 10, 2017 by and among INVUITY, INC, and any additional borrower that hereafter becomes party hereto, each as Borrower, and collectively as Borrowers, and MIDCAP FINANCIAL TRUST, as Agent and as a Lender, and THE ADDITIONAL LENDERS FROM TIME TO TIME PARTY HERETO TABLE OF CONTENTS Page ARTICLE 1 ? DEFINITIONS
March 16, 2017	EX-10.7	Credit and Security Agreement (Revolving Loan), dated as of March 10, 2017, by and among Invuity, Inc., MidCap Financial Trust, as Agent, and the lenders party thereto. Exhibit 10.7 Execution Version CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) dated as of March 10, 2017 by and among INVUITY, INC, and any additional borrower that hereafter becomes party hereto, each as Borrower, and collectively as Borrowers, and MIDCAP FINANCIAL TRUST, as Agent and as a Lender, and THE ADDITIONAL LENDERS FROM TIME TO TIME PARTY HERETO TABLE OF CONTENTS Page ARTICLE 1 – DEFINIT
March 16, 2017	EX-4.7	Warrant to Purchase Stock, dated as of March 10, 2017, by Invuity, Inc. in favor of MidCap Funding VII Trust. Exhibit 4.7 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF SECTION 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW, OR S
March 16, 2017	EX-4.8	Warrant to Purchase Stock, dated as of March 10, 2017, by Invuity, Inc. in favor of Apollo Investment Corporation. Exhibit 4.8 THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF SECTION 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW, OR S
March 10, 2017	SC 13G/A	IVTY / Invuity, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) February 28, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule
February 14, 2017	EX-99.1	INVUITY REPORTS 2016 FOURTH QUARTER, ANNUAL FINANCIAL RESULTS Achieves revenue growth of 50% and gross margin expansion over prior year’s fourth quarter Exhibit991 Exhibit 99.1 NEWS RELEASE INVUITY REPORTS 2016 FOURTH QUARTER, ANNUAL FINANCIAL RESULTS Achieves revenue growth of 50% and gross margin expansion over prior year’s fourth quarter SAN FRANCISCO, February 14, 2017 - Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today reported financial results for the three months and year ended Decem
February 14, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition ivtyCurrentFolio8K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 14, 2017 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission Fi
February 14, 2017	EX-99.A	JOINT FILING AGREEMENT EXHIBIT A CUSIP No. 46187J205 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other reporting persons on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, par value $0.001 per share of Invuity, Inc.
February 14, 2017	SC 13G/A	IVTY / Invuity, Inc. / HealthCare Royalty Partners II, L.P. - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1)* Under the Securities Exchange Act of 1934 INVUITY, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J205 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule purs
February 14, 2017	SC 13G/A	IVTY / Invuity, Inc. / Flynn James E Passive Investment SC 13G/A 1 e615748sc13ga-invuity.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 4) * Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) December 31, 2016
February 14, 2017	SC 13G/A	Invuity SC 13G/A (Passive Acquisition of More Than 5% of Shares) SC 13G/A OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2010 Estimated average burden hours per response 10.
February 14, 2017	SC 13G/A	IVTY / Invuity, Inc. / SAWYER PHILIP M - SC 13G/A Passive Investment SC 13G/A 1 a17-43291sc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Invuity, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 46187J 205 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design
February 14, 2017	EX-99.A	Joint Filing Statement EX-99.A EXHIBIT A Joint Filing Statement We, the undersigned, hereby express our agreement that the attached Schedule 13G is filed on behalf of each of us. Date: February 14, 2017 INTERWEST PARTNERS X, LP By: InterWest Management Partners X, LLC, its General Partner By: /s/ Gilbert H. Kliman Managing Director INTERWEST MANAGEMENT PARTNERS X, LLC By: /s/ Gilbert H. Kliman Managing Director By: /s/
February 14, 2017	SC 13G	IVTY / Invuity, Inc. / HARTFORD MUTUAL FUNDS INC/CT - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) 12/31/2016 (Date of Event Which Requires
February 9, 2017	SC 13G/A	Invuity SEC SCHEDULE 13G (Passive Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule
February 9, 2017	SC 13G/A	IVTY / Invuity, Inc. / Hadley Harbor Master Investors (Cayman) L.P. - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig
February 8, 2017	SC 13G/A	IVTY / Invuity, Inc. / Novo A/S - SC 13G/A (AMENDMENT NO. 2) Passive Investment SC 13G/A (Amendment No. 2) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Invuity, Inc. (Name of Issuer) Common Stock (Title of class of securities) 46187J205 (CUSIP number) December 31, 2016 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursu
January 30, 2017	S-8	Invuity S-8 As filed with the Securities and Exchange Commission on January 30, 2017 Registration No.
January 5, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 5, 2017 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Emplo
January 5, 2017	EX-99.1	INVUITY APPOINTS ANDY SALE AS SVP OF GLOBAL SALES Announces preliminary 2016 fourth quarter and full-year revenue Reiterates 2017 revenue guidance Ex99101052017 Exhibit 99.1 NEWS RELEASE INVUITY APPOINTS ANDY SALE AS SVP OF GLOBAL SALES Announces preliminary 2016 fourth quarter and full-year revenue Reiterates 2017 revenue guidance SAN FRANCISCO, January 5, 2017 - Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced the appointment of Andy Sale as Senior Vice President of Global Sales. Mr. Sale brings over 17 ye
January 5, 2017	EX-24	LIMITED POWER OF ATTORNEY ? SECURITIES LAW COMPLIANCE Exhibit 24 LIMITED POWER OF ATTORNEY ? SECURITIES LAW COMPLIANCE The undersigned, as a Section 16 reporting person of Invuity, Inc.
December 14, 2016	SC 13G/A	IVTY / Invuity, Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.
December 12, 2016	SC 13G/A	IVTY / Invuity, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) November 30, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig
November 10, 2016	EX-99	Joint Filer Information Unassociated Document Joint Filer Information Names: Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Special Situations Fund, L.P. Address: 780 Third Avenue, 37th Floor New York, NY 10017 Designated Filer: James E. Flynn Issuer and Ticker Symbol: Invuity, Inc. [IVTY] Date of Event Requiring Statement: November 10, 2016 The undersigned, Deerfield Mgmt, L.P., Deerfield Management
November 10, 2016	SC 13G/A	IVTY / Invuity, Inc. / Flynn James E Passive Investment SC 13G/A 1 e615567sc13ga-invuity.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2) * Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) November 10, 2016
November 10, 2016	SC 13G/A	IVTY / Invuity, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) October 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule
November 3, 2016	8-K	Invuity 8-K (Current Report/Significant Event) ivtyCurrentFolio8K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 3, 2016 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission Fil
November 3, 2016	EX-99.1	INVUITY REPORTS 2016 THIRD QUARTER, NINE-MONTH FINANCIAL RESULTS Updates 2016 revenue guidance and introduces 2017 revenue guidance Received FDA 510(k) clearance for PhotonBlade™ Exhibit99.1 Exhibit 99.1 NEWS RELEASE INVUITY REPORTS 2016 THIRD QUARTER, NINE-MONTH FINANCIAL RESULTS Updates 2016 revenue guidance and introduces 2017 revenue guidance Received FDA 510(k) clearance for PhotonBlade? SAN FRANCISCO, November 3, 2016 - Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today reported financial results for the third quarter and nine-months ended Septe
November 3, 2016	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10‑Q Table of Contents ty UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
July 29, 2016	8-K	Invuity FORM 8-K (Current Report/Significant Event) Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 28, 2016 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File No.) (IRS E
July 29, 2016	EX-1.1	2,800,000 Shares Invuity, Inc. Common Stock PURCHASE AGREEMENT EX-1.1 EXHIBIT 1.1 Execution Version 2,800,000 Shares Invuity, Inc. Common Stock PURCHASE AGREEMENT July 28, 2016 PIPER JAFFRAY & CO.; LEERINK PARTNERS LLC; As Representatives of the several Underwriters named in Schedule I hereto c/o Piper Jaffray & Co. 800 Nicollet Mall Minneapolis, Minnesota 55402 c/o Leerink Partners LLC 299 Park Avenue, 21st Floor New York, New York 10171 Ladies and Gentlemen
July 29, 2016	EX-99.1	INVUITY ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK EX-99.1 EXHIBIT 99.1 NEWS RELEASE INVUITY ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK SAN FRANCISCO, July 28, 2016Invuity, Inc. (NASDAQ:IVTY) (Invuity or the Company), a leading surgical photonics company, today announced the pricing of its public offering of 2.8 million shares of its common stock at a price to the public of $10.00 per share. In addition, the Company has granted the
July 28, 2016	424B5	William Blair The date of this prospectus supplement is July 28, 2016. 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-212395 PROSPECTUS SUPPLEMENT (To Prospectus dated July 21, 2016) 2,800,000 Shares INVUITY, INC. Common Stock $10.00 per share We are offering 2,800,000 shares of our common stock. Our common stock is listed on the NASDAQ Global Market, or NASDAQ, under the trading symbol ?IVTY.? On July 27, 2016, the last sale price of o
July 27, 2016	424B5	Subject to completion, dated July 27, 2016 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-212395 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are part of an effective registration statement filed with the Securities and Exchange Commission. This preliminary prospectus supplement and the acco
July 20, 2016	EX-10.16	Executive Severance Agreement, dated May 10, 2016, by and between the Registrant and Philip Sawyer. Exhibit 10.16 INVUITY, INC. EXECUTIVE SEVERANCE AGREEMENT This Executive Severance Agreement (the “Agreement”) is entered into by and between Invuity, Inc. (the “Company”), and Philip Sawyer (“Executive”) as of the date set forth on the signature page below (the “Effective Date”). This Agreement, together with the Executive Employment Agreement and Executive Change of Control Agreement, each dated
July 20, 2016	EX-10.17	Executive Change of Control Agreement, dated May 10, 2016, by and between the Registrant and James Mackaness. Exhibit 10.17 INVUITY, INC. EXECUTIVE CHANGE OF CONTROL AGREEMENT This Executive Change of Control Agreement (the “Agreement”) is entered into by and between Invuity, Inc. (the “Company”), and James Mackaness (“Executive”) as of the date set forth on the signature page below (the “Effective Date”). This Agreement, together with the Executive Change of Control Agreement dated as of even date herewi
July 20, 2016	EX-10.14	Executive Employment Agreement, dated May 10, 2016, by and between the Registrant and Philip Sawyer. Exhibit 10.14 INVUITY, INC. EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement (the ?Agreement?) is entered into by and between Invuity, Inc. (the ?Company?), and Philip Sawyer (?Executive?) as of the date set forth on the signature page below (the ?Effective Date?). This Agreement, together with the Executive Severance Agreement and Executive Change of Control Agreement, each dated as of ev
July 20, 2016	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10‑Q ivty-10q20160630.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10?Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37
July 20, 2016	EX-10.15	Executive Change of Control Agreement, dated May 10, 2016, by and between the Registrant and Philip Sawyer. Exhibit 10.15 INVUITY, INC. EXECUTIVE CHANGE OF CONTROL AGREEMENT This Executive Change of Control Agreement (the “Agreement”) is entered into by and between Invuity, Inc. (the “Company”), and Philip Sawyer (“Executive”) as of the date set forth on the signature page below (the “Effective Date”). This Agreement, together with the Executive Employment Agreement and Executive Change of Control Agree
July 20, 2016	EX-10.18	Executive Severance Agreement, dated May 10, 2016, by and between the Registrant and James Mackaness. Exhibit 10.18 INVUITY, INC. EXECUTIVE SEVERANCE AGREEMENT This Executive Severance Agreement (the “Agreement”) is entered into by and between Invuity, Inc. (the “Company”), and James Mackaness (“Executive”) as of the date set forth on the signature page below (the “Effective Date”). This Agreement, together with the Executive Change of Control Agreement dated as of even date herewith, replaces and
July 19, 2016	EX-99.1	INVUITY REPORTS 2016 SECOND QUARTER AND SIX-MONTH FINANCIAL RESULTS Achieves 73 percent year-over-year revenue growth ivty-ex9916.htm Exhibit 99.1 NEWS RELEASE INVUITY REPORTS 2016 SECOND QUARTER AND SIX-MONTH FINANCIAL RESULTS Achieves 73 percent year-over-year revenue growth SAN FRANCISCO, July 19, 2016 - Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today reported financial results for the second quarter and six months ended June 30, 2016. Q2 2016 Highlights · Revenue grew 73 percent to $8
July 19, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition ivty-8k20160719.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 19, 2016 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File
July 19, 2016	CORRESP	Invuity ESP CORRESP July 19, 2016 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.
July 1, 2016	EX-1.2	Invuity, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement EX-1.2 Exhibit 1.2 Invuity, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement July 1, 2016 Cantor Fitzgerald & Co. 499 Park Avenue New York, NY 10022 Ladies and Gentlemen: Invuity, Inc., a Delaware corporation (the Company), confirms its agreement (this Agreement) with Cantor Fitzgerald & Co. (the Agent), as follows: 1. Issuance and Sale of
July 1, 2016	S-3	Invuity FORM S-3 FORM S-3 Table of Contents As filed with the Securities and Exchange Commission on July 1, 2016 Registration No.
May 24, 2016	8-K	Invuity 8-K (Current Report/Significant Event) ivty-8k20160524.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 19, 2016 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File N
May 11, 2016	8-K	Invuity 8-K (Current Report/Significant Event) ivty-8k20160511.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 11, 2016 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File N
May 5, 2016	EX-99.1	INVUITY REPORTS 2016 FIRST QUARTER RESULTS ivty-ex9916.htm Exhibit 99.1 NEWS RELEASE INVUITY REPORTS 2016 FIRST QUARTER RESULTS SAN FRANCISCO, May 5, 2016 - Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today reported financial results for the first quarter ended March 31, 2016. Q1 2016 Highlights · Revenue grew 44% to $6.4 million compared to revenue of $4.4 million in the 2015 first quarter. · Gross margin improved t
May 5, 2016	8-K	Invuity 8-K (Current Report/Significant Event) ivty-8k20160331.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 5, 2016 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File Nu
May 5, 2016	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10‑Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10‑Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37417 INVUITY, INC. (E
April 25, 2016	EX-24	EX-24 LIMITED POWER OF ATTORNEY - SECURITIES LAW COMPLIANCE The undersigned, as a Section 16 reporting person of Invuity, Inc.
April 8, 2016	DEFA14A	Invuity DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Pro
April 8, 2016	DEF 14A	Invuity DEF 14A DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 25, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K 1 ivty-8k20160323.htm 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 22, 2016 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commi
March 25, 2016	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-37417 Invuity, Inc. (
March 25, 2016	EX-10.12	May 22, 2015 Exhibit 10.12 May 22, 2015 Susan H. Martin * * Re: Your Employment with Invuity, Inc. Dear Susan: Invuity, Inc. (the ?Company?) is pleased to offer you employment with the Company on the terms described below. 1. Position. You will serve in a full-time position as the Vice President of Marketing starting May 26, 2015 (your ?Hire Date?) and you will report to the Company?s Chief Executive Offic
March 25, 2016	EX-10.13	Executive Employment Agreement, dated July 28, 2015, by and between the Registrant and James Mackaness. Exhibit 10.13 INVUITY, INC. EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement (the ?Agreement?) is entered into by and between Invuity, Inc. (the ?Company?), and James Mackaness (?Executive?) as of the date the Company and Executive have each executed this Agreement, as set forth below. The terms of this Agreement will become effective on the Executive?s first day of employment, August 24,
February 26, 2016	8-K	Invuity 8-K (Current Report/Significant Event) 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 23, 2016 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File No.) (IRS Em
February 24, 2016	EX-99.1	INVUITY REPORTS 2015 FOURTH QUARTER, YEAR-END FINANCIAL RESULTS ivty-ex9916.htm Exhibit 99.1 NEWS RELEASE INVUITY REPORTS 2015 FOURTH QUARTER, YEAR-END FINANCIAL RESULTS SAN FRANCISCO, February 24, 2016 - Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today reported financial results for the fourth quarter and year ended December 31, 2015. Q4 2015 Highlights ? Revenue grew 42 percent to $6.2 million compared to revenue of $4.4 million in
February 24, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 24, 2016 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File Num
February 22, 2016	EX-24	EX-24 LIMITED POWER OF ATTORNEY - SECURITIES LAW COMPLIANCE The undersigned, as a Section 16 reporting person of Invuity, Inc.
February 16, 2016	SC 13G	Invuity SC 13G (Passive Acquisition of More Than 5% of Shares) SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. )* Under the Securities Exchange Act of 1934 INVUITY, INC. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 46187J205 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rul
February 16, 2016	EX-99.A	JOINT FILING AGREEMENT EX-99.A CUSIP No. 46187J205 EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other reporting persons on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, par value $0.001 per share of Invui
February 16, 2016	SC 13G	IVTY / Invuity, Inc. / SAWYER PHILIP M - SC 13G Passive Investment SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Invuity, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 46187J 205 (CUSIP Number) December 31, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi
February 16, 2016	SC 13G/A	IVTY / Invuity, Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.
February 12, 2016	SC 13G	Invuity SC 13G (Passive Acquisition of More Than 5% of Shares) SC 13G OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2010 Estimated average burden hours per response 10.
February 12, 2016	EX-99.A	Joint Filing Statement EX-99.A EXHIBIT A Joint Filing Statement We, the undersigned, hereby express our agreement that the attached Schedule 13G is filed on behalf of each of us. Date: February 12, 2016 INTERWEST PARTNERS X, LP By: InterWest Management Partners X, LLC its General Partner By: /s/ Gilbert H. Kliman By: /s/ Bruce A. Cleveland Managing Director Name: Bruce A. Cleveland INTERWEST MANAGEMENT PARTNERS X, LLC B
February 11, 2016	SC 13G/A	IVTY / Invuity, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule
February 10, 2016	SC 13G/A	IVTY / Invuity, Inc. / Novo A/S - SC 13G/A Passive Investment SC 13G/A 1 d64970dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Invuity, Inc. (Name of Issuer) Common Stock (Title of class of securities) 46187J 10 6 (CUSIP number) December 31, 2015 (Date of event which requires filing of this statement) Check the appropriate box to designate t
December 22, 2015	SC 13G	IVTY / Invuity, Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.
November 30, 2015	8-K	Invuity FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 23, 2015 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission
November 30, 2015	EX-99.1	INVUITY NAMES GREG LUCIER CHAIRMAN EX-99.1 Exhibit 99.1 NEWS RELEASE INVUITY NAMES GREG LUCIER CHAIRMAN SAN FRANCISCO, November 30, 2015 - Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, announced today that life sciences industry luminary Gregory T. Lucier has been appointed to the role of Chairman of its Board of Directors, effective December 31, 2015. Lucier, who is the chief executive officer of Nuvasive, I
November 12, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-
November 10, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 10, 2015 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File No.) (IRS Employ
November 10, 2015	EX-99.1	INVUITY REPORTS 2015 THIRD QUARTER, NINE-MONTH FINANCIAL RESULTS EX-99.1 Exhibit 99.1 NEWS RELEASE INVUITY REPORTS 2015 THIRD QUARTER, NINE-MONTH FINANCIAL RESULTS SAN FRANCISCO, November 10, 2015 - Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today reported financial results for the third quarter and nine-months ended September 30, 2015. Q3 2015 Highlights Revenue grew 50% to $5.6 million compared to revenue of $3.7 million in the 201
August 25, 2015	EX-24	EX-24 LIMITED POWER OF ATTORNEY - SECURITIES LAW COMPLIANCE The undersigned, as a Section 16 reporting person of Invuity, Inc.
August 12, 2015	EX-3.1	Amended and Restated Certificate of Incorporation. Exhibit 3.1 INVUITY, INC. AMENDED AND RESTATED CERTIFICATE OF INCORPORATION Invuity, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Company?), hereby certifies as follows: A. The name of the Company is Invuity, Inc., and the original Certificate of Incorporation of this Company was filed with the Secretary of State of the State of Delaware on April 6, 2015
August 12, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
August 12, 2015	EX-3.3	Amended and Restated Bylaws of the Registrant. Exhibit 3.3 AMENDED AND RESTATED BYLAWS OF INVUITY, INC. (effective as of June 18, 2015, the closing of the corporation?s initial public offering) TABLE OF CONTENTS Page ARTICLE I ? CORPORATE OFFICES 1 1.1 REGISTERED OFFICE 1 1.2 OTHER OFFICES 1 ARTICLE II ? MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS 1 2.2 ANNUAL MEETING 1 2.3 SPECIAL MEETING 1 2.4 ADVANCE NOTICE PROCEDURES 2 2.5 NOTICE OF S
August 12, 2015	8-K	Invuity FORM 8-K (Current Report/Significant Event) Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 11, 2015 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File No.) (IRS
August 12, 2015	EX-3.2	Certificate of Amendment to the Amended and Restated Certificate of Incorporation. Exhibit 3.2 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INVUITY, INC. Invuity, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), certifies that: 1. The name of the Corporation is Invuity, Inc. The Corporation?s original Certificate of Incorporation was filed with the Secretary of State of the State of De
August 11, 2015	EX-99.1	INVUITY REPORTS 2015 SECOND QUARTER, SIX-MONTH FINANCIAL RESULTS Second Quarter Revenue Increased 69 Percent Over Prior Year Period EX-99.1 Exhibit 99.1 INVUITY REPORTS 2015 SECOND QUARTER, SIX-MONTH FINANCIAL RESULTS Second Quarter Revenue Increased 69 Percent Over Prior Year Period SAN FRANCISCO, August 11, 2015 - Invuity, Inc. (NASDAQ:IVTY), a medical technology company, today reported financial results for the second quarter and six-months ended June 30, 2015. Q2 2015 Highlights Revenue grew 69 percent to $4.7 million co
August 11, 2015	8-K	Invuity FORM 8-K (Current Report/Significant Event) Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 11, 2015 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File No.) (IRS
August 10, 2015	EX-99.1	INVUITY NAMES JAMES H. MACKANESS CHIEF FINANCIAL OFFICER EX-99.1 Exhibit 99.1 INVUITY NAMES JAMES H. MACKANESS CHIEF FINANCIAL OFFICER SAN FRANCISCO, August 10, 2015 - Invuity, Inc. (NASDAQ:IVTY), a medical technology company, today announced the appointment of medical device financial and operations executive James H. Mackaness as its Chief Financial Officer, effective August 24th. Mackaness will report directly to President and CEO Philip Sawyer. Mack
August 10, 2015	8-K	Invuity FORM 8-K (Current Report/Significant Event) Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 10, 2015 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File No.) (IRS
July 27, 2015	8-K	Invuity FORM 8-K (Current Report/Significant Event) Form 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 24, 2015 INVUITY, INC. (Exact name of registrant as specified in its charter) Delaware 001-37417 04-3803169 (State or other jurisdiction of incorporation) (Commission File No.) (IRS E
July 10, 2015	SC 13G	Invuity SEC SCHEDULE 13G (Passive Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) June 30, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fi
June 29, 2015	SC 13G	IVTY / Invuity, Inc. / Novo A/S - SC 13G Passive Investment SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Invuity, Inc. (Name of Issuer) Common Stock (Title of class of securities) 46187J 10 6 (CUSIP number) June 18, 2015 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this Sched
June 25, 2015	SC 13G	IVTY / Invuity, Inc. / Hadley Harbor Master Investors (Cayman) L.P. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) June 15, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fi
June 25, 2015	SC 13G	IVTY / Invuity, Inc. / Hadley Harbor Master Investors (Cayman) L.P. - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Invuity, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 46187J205 (CUSIP Number) June 15, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fi
June 16, 2015	424B4	TABLE OF CONTENTS Page Prospectus Summary 1 Risk Factors 12 Special Note Regarding Forward-Looking Statements 42 Market and Industry Data 44 Use of Proceeds 45 Dividend Policy 46 Capitalization 47 Dilution 49 Selected Financial Data 51 Managements D 424B4 1 d852944d424b4.htm 424B4 Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-203505 INVUITY intelligent photonics TM The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securitie
June 15, 2015	CORRESP	Invuity ESP CORRESP 1 filename1.htm June 15, 2015 Via EDGAR and Courier Service Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Amanda Ravitz Heather Percival Kristen Lochhead Gary Todd Re: Invuity, Inc. Post-Effective Amendment No. 1 to Registration Statement on Form S-1 Filed June 12, 2015 File No. 333-203505 Ladies and Gentlemen:
June 15, 2015	FWP	Invuity, Inc. Prices Initial Public Offering of 4,000,000 Shares of Common Stock Supplements information in preliminary prospectus dated June 11, 2015 FWP Filed Pursuant to Rule 433 of the Securities Act of 1933 Issuer Free Writing Prospectus dated June 15, 2015 Relating to Preliminary Prospectus dated June 12, 2015 Registration No.
June 15, 2015	CORRESP	Invuity ESP June 15, 2015 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.
June 15, 2015	S-8	Invuity FORM S-8 FORM S-8 As filed with the Securities and Exchange Commission on June 15, 2015 Registration No.
June 15, 2015	CORRESP	Invuity ESP CORRESP Piper Jaffray & Co. 800 Nicollet Mall Minneapolis, Minnesota 55402 Leerink Partners LLC 299 Park Avenue, 21st Floor New York, NY 10171 June 15, 2015 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: Invuity, Inc. Post-Effective Amendment No. 1 to Registration Statement on Form S-1 (File No. 333-203505) Ladies and Gentle
June 12, 2015	POS AM	As filed with the Securities and Exchange Commission on June 12, 2015. POS AM Table of Contents As filed with the Securities and Exchange Commission on June 12, 2015.
June 11, 2015	EX-24.1	EX-24.1 POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS: The undersigned, Bruce A. Cleveland, hereby constitutes and appoints Karen A. Wilson as his true and lawful Attorney-in-Fact, with full power in his name and on his behalf, to take all actions and do all things necessary with respect to all matters arising in connection with the ownership reporting requirements of the securities laws of the United Stat
June 11, 2015	EX-24	EX-24 LIMITED POWER OF ATTORNEY - SECURITIES LAW COMPLIANCE The undersigned, as a Section 16 reporting person of Invuity, Inc.
June 11, 2015	EX-99	EX-99 Exhibit 99 FORM 3 JOINT FILER INFORMATION Name of "Reporting Persons": InterWest Partners X, L.
June 11, 2015	EX-24.3	EX-24.3 POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS: The undersigned, Philip T. Gianos, hereby constitutes and appoints Karen A. Wilson as his true and lawful Attorney-in-Fact, with full power in his name and on his behalf, to take all actions and do all things necessary with respect to all matters arising in connection with the ownership reporting requirements of the securities laws of the United States
June 11, 2015	EX-24	EX-24 LIMITED POWER OF ATTORNEY - SECURITIES LAW COMPLIANCE The undersigned, as a Section 16 reporting person of Invuity, Inc.
June 11, 2015	EX-24.7	EX-24.7 POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS: The undersigned, Khaled A. Nasr, hereby constitutes and appoints Karen A. Wilson as his true and lawful Attorney-in-Fact, with full power in his name and on his behalf, to take all actions and do all things necessary with respect to all matters arising in connection with the ownership reporting requirements of the securities laws of the United States,
June 11, 2015	EX-24.6	EX-24.6 POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS: The undersigned, Gilbert H. Kliman, hereby constitutes and appoints Karen A. Wilson as his true and lawful Attorney-in-Fact, with full power in his name and on his behalf, to take all actions and do all things necessary with respect to all matters arising in connection with the ownership reporting requirements of the securities laws of the United State
June 11, 2015	EX-24.6	EX-24.6 POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS: The undersigned, Gilbert H. Kliman, hereby constitutes and appoints Karen A. Wilson as his true and lawful Attorney-in-Fact, with full power in his name and on his behalf, to take all actions and do all things necessary with respect to all matters arising in connection with the ownership reporting requirements of the securities laws of the United State
June 11, 2015	EX-24	EX-24 LIMITED POWER OF ATTORNEY - SECURITIES LAW COMPLIANCE The undersigned, as a Section 16 reporting person of Invuity, Inc.
June 11, 2015	EX-24	EX-24 LIMITED POWER OF ATTORNEY - SECURITIES LAW COMPLIANCE The undersigned, as a Section 16 reporting person of Invuity, Inc.
June 11, 2015	EX-24	EX-24 LIMITED POWER OF ATTORNEY - SECURITIES LAW COMPLIANCE The undersigned, as a Section 16 reporting person of Invuity, Inc.
June 11, 2015	EX-24.8	EX-24.8 POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS: The undersigned, Arnold L. Oronsky, hereby constitutes and appoints Karen A. Wilson as his true and lawful Attorney-in-Fact, with full power in his name and on his behalf, to take all actions and do all things necessary with respect to all matters arising in connection with the ownership reporting requirements of the securities laws of the United State

IVTY / Invuity, Inc. - SEC फाइलिंग, वार्षिक रिपोर्ट, प्रॉक्सी स्टेटमेंट

मूलभूत आँकड़े

SEC Filings

SEC Filings (Chronological Order)